During the past decade, Department of Medicine I, University of Erlangen-Nuremberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Medicine I, University of Erlangen-Nuremberg" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biosyn" with 1 trials as a collaborator, "Brahms AG" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Department of Medicine I, University of Erlangen-Nuremberg" are "Septic Shock" (2 trials), "Severe Sepsis" (2 trials), "Crohn's Disease" (1 trials), "Crohn´s Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Department of Medicine I, University of Erlangen-Nuremberg" in a lesser frequency.

Most popular intervention types in "Department of Medicine I, University of Erlangen-Nuremberg" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Procalcitonin guided therapy" (1 trials), "meropenem" (1 trials), "meropenem, moxifloxacin" (1 trials) and "sodium-selenite" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Medicine I, University of Erlangen-Nuremberg" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Department of Medicine I, University of Erlangen-Nuremberg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Medicine I, University of Erlangen-Nuremberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Medicine I, University of Erlangen-Nuremberg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".